Latest News and Press Releases
Want to stay updated on the latest news?
-
Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week
COPENHAGEN, Denmark, January 7, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will present at the Biotech...
-
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases,...
-
SAN MATEO, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Freshworks (NASDAQ: FRSH), today announced Kady Srinivasan has joined as its Chief Marketing Officer, bringing over 15 years of leadership...
-
PARIS, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory T cells (Tregs) to rebalance...
-
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) today announced that Apollo-managed funds and affiliates (the “Apollo Funds”) have led a $3.5 billion capital solution for Valor...
-
BOCA RATON, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vocodia Holdings Corp (OTC: VHAI) (“Vocodia” or the “Company”), a pioneer in AI-driven customer engagement solutions, today announced it has...
-
Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as...
-
New Strategic Partnerships with The Hockey News and Expansion of Elite Journalist Network to 150+ Former Sports Illustrated Media Professionals SAN DIEGO, CA, Jan. 07, 2026 (GLOBE NEWSWIRE) --...
-
David Zaccardelli, Pharm.D. joins Board as Chair Rita Jain, M.D., joins Board as an Independent Director MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a...
-
MIAMI, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Captivision Inc. (“Captivision” or the “Company”) (Nasdaq: CAPT), today announced that it has been informed that the Nasdaq Hearings Panel (the “Panel”) has...
-
ATLANTA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Gray Media, Inc. has named Kristy Santiago as the next General Manager of KFVS (CBS and CW) in Cape Girardeau, Missouri and WQWQ-LD (Telemundo) in Paducah,...
-
Initial design and prototype order valued at approximately $1.2 million Integration of OSS hardware into prime contractor system further validates OSS capabilities for next-generation 360-degree...
-
BGB Group strengthens pharma commercialization capabilities by integrating Hayden's payer and reimbursement expertise into its advisory practice.
-
DURANGO, Colo., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rocky Mountain Chocolate Factory Inc. (Nasdaq: RMCF) (the “Company”, “we”, or “RMCF”), America’s Chocolatier™ and a leading franchiser of a premium...
-
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- WarHorse Gaming announced today it has deployed Context Networks’ Contextual Promotions Media Network™ (CPMN™) powered by Mobiquity Technologies’ (OTCQB:...
-
– Common warts affects approximately 22 million patients in the United States alone, and there are no FDA approved prescription therapies for what is believed to be a multibillion-dollar market...
-
TAMPA, Fla., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Upexi, Inc. (NASDAQ: UPXI), a leading Solana-focused digital asset treasury company and consumer brands owner, announced that it will implement a...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation...
-
Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Western Europe Existing & Upcoming Data Center Portfolio" report has been added to ResearchAndMarkets.com's offering. Western Europe hosts...
-
Chicago, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The global immuno-oncology drugs market was valued at US$ 35.78 billion in 2025 and is expected to reach US$ 185.69 billion by 2035, growing at a CAGR of...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
Singapore, SG, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Indocia today announced that its VIP Whitelisting Round for the $INDO token presale is now live, with limited seats remaining ahead of the upcoming...
-
Wellington, New Zealand, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pokiemachines, a new site about pokie machines, announced the results of a comprehensive behavioral study examining how players interact...
-
New York City, Jan. 07, 2026 (GLOBE NEWSWIRE) -- By 2026, the U.S. online gambling landscape is advancing at an unprecedented pace, shaped largely by player demand for secure payment methods...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
Dublin, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The "Batch Record Review and Product Release (Jan 13, 2026)" training has been added to ResearchAndMarkets.com's offering.This course shows how to review...
-
Downing LLPLEI: 213800G3X76VBG9SB50407 January 2026Form 8.3 re. Inspecs Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING...
-
Julie & Holleman LLP is investigating potential misconduct committed by Fiserv's directors and officers.
-
Julie & Holleman LLP is investigating potential misconduct at Stride, Inc.
-
GREENWICH, Conn., Jan. 07, 2026 (GLOBE NEWSWIRE) -- XPO (NYSE: XPO), a leading provider of freight transportation in North America, announced that it has renewed its long-standing commitment as the...
-
Julie & Holleman LLP is investigating potential misconduct by KinderCare's officers and directors.
-
Downing LLPLEI: 213800G3X76VBG9SB50407 January 2026Form 8.3 re. Frenkel Topping Group Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES...
-
Downing LLPLEI: 213800G3X76VBG9SB50407 January 2026Form 8.3 re. 1Spatial Plc PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR...
-
Chicago, Jan. 07, 2026 (GLOBE NEWSWIRE) -- The global unmanned underwater vehicles market was valued at US$ 5.49 billion in 2025 and is projected to hit the market valuation of US$ 46.62 billion by...
-
BURLINGTON, Mass. and JERUSALEM, Jan. 07, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation...
-
Austin, Texas, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Orthopedic Braces Market Size & Growth Analysis: According to SNS Insider, the Orthopedic Braces Market is estimated at USD 4.82 billion in 2025...
-
LOUISVILLE, Ky., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- VR Resources Limited (“VR” or the...
-
WOODLAND PARK, N.J., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Anterix, Inc. (NASDAQ: ATEX) today announced the appointment of Ross Spero as Chief Product Officer. Spero will lead Anterix’s product...
-
Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative therapies, including OPZELURA®, povorcitinib, ILUMYA®, ODOMZO®, REMICADE®, and...
-
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
-
Stardust Power Engages 38 North Solutions To Support Federal Government Relations
-
Name change to Kyntra Bio reflects the newly sharpened focus of the Company on novel therapies with potential for outsized impact in oncology and rare diseaseKyntra Bio will begin trading on Nasdaq...
-
WALTHAM, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically...
-
TORONTO & PALO ALTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- FreshBooks, a platform designed to simplify the financial complexity of running a service based small business, today announced a strategic...
-
NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 44th...
-
Extends Arlington Valley (Arlington) tolling agreement with the current counterparty by 7 years through 2038, increasing the remaining contract life to 13 yearsAdds 35 MW of incremental capacity to...
-
Sotera Health to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
TappAlpha and Tuttle Capital Launch the T² Lift™ Series with TSYX and TDAX